ロゴ

研究について

論文

1 Chondroitin sulfate protects vascular endothelial cells from toxicities of extracellular histones.
Nagano F, Mizuno T, Mizumoto S, Yoshioka K, Takahashi K, Tsuboi N, Maruyama S, Yamada S, Nagamatsu T.
Eur J Pharmacol. 2018 Mar 6;826:48-55.
2 Clinical features and pathogenesis of membranoproliferative glomerulonephritis: a nationwide analysis of the Japan renal biopsy registry from 2007 to 2015.
Nakagawa N, Hasebe N, Hattori M, Nagata M, Yokoyama H, Sato H, Sugiyama H, Shimizu A, Isaka Y, Maruyama S, Narita I.
Clin Exp Nephrol. 2018 Aug;22(4):797-807.
3 Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.
Mizuno M, Suzuki Y, Ito Y.
Clin Exp Nephrol. 2018 Feb;22(1):3-14.
4 Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
Shimizu M, Furuichi K, Toyama T, Funamoto T, Kitajima S, Hara A, Ogawa D, Koya D, Ikeda K, Koshino Y, Kurokawa Y, Abe H, Mori K, Nakayama M, Konishi Y, Samejima KI, Matsui M, Yamauchi H, Gohda T, Fukami K, Nagata D, Yamazaki H, Yuzawa Y, Suzuki Y, Fujimoto S, Maruyama S, Kato S, Naito T, Yoshimura K, Yokoyama H, Wada T; Research Group of Diabetic Nephropathy, the Ministry of Health, Labour, and Welfare of Japan and Japan Agency for Medical Research and Development.
Clin Exp Nephrol. 2018 Apr;22(2):377-387.
5 Ratio of blood urea nitrogen to serum creatinine at initiation of dialysis is associated with mortality: a multicenter prospective cohort study.
Inaguma D, Koide S, Ito E, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y; AICOPP group.
Clin Exp Nephrol. 2018 Apr;22(2):353-364.
6 Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).
Kato H, Nangaku M, Hirakata H, Wada T, Hayashi T, Sato H, Yamazaki Y, Masaki T, Kagimura T, Yamamoto H, Hase H, Kamouchi M, Imai E, Mizuno K, Iwasaki M, Akizawa T, Tsubakihara Y, Maruyama S, Narita I.
Clin Exp Nephrol. 2018 Feb;22(1):78-84.
7 Rationale and study design of a clinical trial to assess the effects of LDL apheresis on proteinuria in diabetic patients with severe proteinuria and dyslipidemia.
Wada T, Muso E, Maruyama S, Hara A, Furuichi K, Yoshimura K, Miyazaki M, Sato E, Abe M, Shibagaki Y, Narita I, Yokoyama H, Mori N, Yuzawa Y, Matsubara T, Tsukamoto T, Wada J, Ito T, Masutani K, Tsuruya K, Fujimoto S, Tsuda A, Suzuki H, Kasuno K, Terada Y, Nakata T, Iino N, Kobayashi S.
Clin Exp Nephrol. 2018 Jun;22(3):591-596.
8 Renoprotective effects of topiroxostat for hyperuremic patients with overt diabetic nephropathy study (ETUDE Study): A prospective, randomized, multicenter clinical trial.
Mizukoshi T, Kato S, Ando M, Sobajima H, Ohashi N, Naruse T, Saka Y, Shimizu H, Nagata T, Maruyama S.
Nephrology (Carlton). 2018 Nov;23(11):1023-1030.
9 TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T, Nishimura H, Mizuno M, Suzuki Y, Matsukawa Y, Sakata F, Maruyama S, Takei Y, Ito Y.
Am J Physiol Renal Physiol. 2018 Feb 1;314(2):F167-F180.
10 The clinical relevance of plasma CD147/basigin in biopsy-proven kidney diseases.
Mori Y, Masuda T, Kosugi T, Yoshioka T, Hori M, Nagaya H, Maeda K, Sato Y, Kojima H, Kato N, Ishimoto T, Katsuno T, Yuzawa Y, Kadomatsu K, Maruyama S.
Clin Exp Nephrol. 2017 Aug;22(4):815-824.
1 Apoptosis inhibitor of macrophage ameliorates fungus-induced peritoneal injury model in mice.
Tomita T, Arai S, Kitada K, Mizuno M, Suzuki Y, Sakata F, Nakano D, Hiramoto E, Takei Y, Maruyama S, Nishiyama A, Matsuo S, Miyazaki T, Ito Y.
Sci Rep. 2017 Jul 25;7(1):6450.
2 Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: A cross-sectional study in Japanese male workers.
Kubo Y, Imaizumi T, Ando M, Nakatochi M, Yasuda Y, Honda H, Kuwatsuka Y, Kato S, Kikuchi K, Kondo T, Iwata M, Nakashima T, Yasui H, Takamatsu H, Okajima H, Yoshida Y, Maruyama S.
PLoS One. 2017 Oct 10;12(10):e0185476.
3 Association of interactions between dietary salt consumption and hypertension-susceptibility genetic polymorphisms with blood pressure among Japanese male workers.
Imaizumi T, Ando M, Nakatochi M, Maruyama S, Yasuda Y, Honda H, Kuwatsuka Y, Kato S, Kondo T, Iwata M, Nakashima T, Yasui H, Takamatsu H, Okajima H, Yoshida Y, Matsuo S.
Clin Exp Nephrol. 2017 Jun;21(3):457-464.
4 Complement component 5 promotes lethal thrombosis.
Mizuno T, Yoshioka K, Mizuno M, Shimizu M, Nagano F, Okuda T, Tsuboi N, Maruyama S, Nagamatsu T, Imai M.
Sci Rep. 2017 Feb 16;7:42714.
5 Efficacy of urinary midkine as a biomarker in patients with acute kidney injury.
Hayashi H, Sato W, Kosugi T, Nishimura K, Sugiyama D, Asano N, Ikematsu S, Komori K, Nishiwaki K, Kadomatsu K, Matsuo S, Maruyama S, Yuzawa Y.
Clin Exp Nephrol. 2017 Aug;21(4):597-607.
6 Growth Factor Midkine Promotes T-Cell Activation through Nuclear Factor of Activated T Cells Signaling and Th1 Cell Differentiation in Lupus Nephritis.
Masuda T, Maeda K, Sato W, Kosugi T, Sato Y, Kojima H, Kato N, Ishimoto T, Tsuboi N, Uchimura K, Yuzawa Y, Maruyama S, Kadomatsu K.
Am J Pathol. 2017 Apr;187(4):740-751.
7 Hexamerization-enhanced CD20 antibody mediates complement-dependent cytotoxicity in serum genetically deficient in C9.
Taylor RP, Lindorfer MA, Cook EM, Beurskens FJ, Schuurman J, Parren PWHI, Zent CS, VanDerMeid KR, Burack R, Mizuno M, Morgan BP.
Clin Immunol. 2017 Aug;181:24-28.
8 High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients.
Mizuno M, Suzuki Y, Higashide K, Sei Y, Iguchi D, Sakata F, Horie M, Maruyama S, Matsuo S, Morgan BP, Ito Y.
PLoS One. 2017 Jan 3;12(1):e0169111.
9 Long-term renal survival of γ3-heavy chain deposition disease: a case report.
Katsuno T, Mizuno S, Mabuchi M, Tsuboi N, Komatsuda A, Maruyama S.
BMC Nephrol. 2017 Jul 17;18(1):239.
10 Mesangial proliferative glomerulonephritis in murine malaria parasite, Plasmodium chabaudi AS, infected NC mice.
Yashima A, Mizuno M, Yuzawa Y, Shimada K, Suzuki N, Tawada H, Sato W, Tsuboi N, Maruyama S, Ito Y, Matsuo S, Ohno T.
Clin Exp Nephrol. 2017 Aug;21(4):589-596.
11 Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.
Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Sasatomi Y, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y; Refractory Nephrotic Syndrome Study Group.
Clin Exp Nephrol. 2017 Dec;21(6):961-970.
12 Postpartum atypical hemolytic uremic syndrome with complement factor H mutation complicated by reversible cerebrovascular constriction syndrome successfully treated with eculizumab.
Yamaguchi M, Hori M, Hiroshi N, Maruyama S.
Thromb Res. 2017 Mar; 151: 79-81.
13 Prediction of response to remission induction therapy by gene expression profiling of peripheral blood in Japanese patients with microscopic polyangiitis.
Ishizu A, Tomaru U, Masuda S, Sada KE, Amano K, Harigai M, Kawaguchi Y, Arimura Y, Yamagata K, Ozaki S, Dobashi H, Homma S, Okada Y, Sugiyama H, Usui J, Tsuboi N, Matsuo S, Makino H; Research Committee of the Intractable Vasculitis Syndrome and the Research Committee of the Intractable Renal Disease of the Ministry of Health, Labour, and Welfare of Japan.
Arthritis Res Ther. 2017 May 31;19(1):117.
14 Randomized controlled trial for assessment of Internet of Things system to guide intensive glucose control in diabetes outpatients: Nagoya Health Navigator Study protocol.
Onoue T, Goto M, Kobayashi T, Tominaga T, Ando M, Honda H, Yoshida Y, Tosaki T, Yokoi H, Kato S, Maruyama S, Arima H.
Nagoya J Med Sci. 2017 Aug;79(3):323-329.
15 Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission.
Inagaki K, Yasuda Y, Ando M, Kaihan AB, Hachiya A, Ozeki T, Hishida M, Imaizumi T, Katsuno T, Kato S, Tsuboi N, Maruyama S.
PLoS One. 2017 Nov 2;12(11):e0187607.
16 Single-Dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-Center Experience.
Katsuno T, Ozaki T, Kim H, Kato N, Suzuki Y, Akiyama S, Ishimoto T, Kosugi T, Tsuboi N, Ito Y, Maruyama S.
Intern Med. 2017;56(13):1679-1686.
17 Sodium chloride promotes tissue inflammation via osmotic stimuli in subtotal-nephrectomized mice.
Sakata F, Ito Y, Mizuno M, Sawai A, Suzuki Y, Tomita T, Tawada M, Tanaka A, Hirayama A, Sagara A, Wada T, Maruyama S, Soga T, Matsuo S, Imai E, Takei Y.
Lab Invest. 2017 Apr; 97(4):432-446.
18 Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis.
Ishizaki J, Takemori A, Suemori K, Matsumoto T, Akita Y, Sada KE, Yuzawa Y, Amano K, Takasaki Y, Harigai M, Arimura Y, Makino H, Yasukawa M, Takemori N, Hasegawa H; Research Committee of Intractable Vasculitis Syndrome and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan.
Arthritis Res Ther. 2017 Sep 29;19(1):218.
19 The association between intensive care unit-acquired hypernatraemia and mortality in critically ill patients with cerebrovascular diseases: a single-centre cohort study in Japan.
Imaizumi T, Nakatochi M, Fujita Y, Nomura R, Watanabe K, Maekawa M, Yamakawa T, Katsuno T, Maruyama S.
BMJ Open. 2017 Aug 18;7(8):e016248.
20 The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients.
Kaihan AB, Yasuda Y, Katsuno T, Kato S, Imaizumi T, Ozeki T, Hishida M, Nagata T, Ando M, Tsuboi N, Maruyama S.
Clin Exp Nephrol. 2017 Dec;21(6):986-994.
21 The Type of Vascular Access and the Incidence of Mortality in Japanese Dialysis Patients.
Ozeki T, Shimizu H, Fujita Y, Inaguma D, Maruyama S, Ohyama Y, Minatoguchi S, Murai Y, Terashita M, Tagaya T.
Intern Med. 2017;56(5):481-485.
22 Unit cost of healthcare services at 200-bed public hospitals in Myanmar: what plays an important role of hospital budgeting?
Than TM, Saw YM, Khaing M, Win EM, Cho SM, Kariya T, Yamamoto E, Hamajima N.
BMC Health Serv Res. 2017 Sep 19;17(1):669.
23 Urinary and circulating levels of the anti-angiogenic isoform of vascular endothelial growth factor-A in patients with chronic kidney disease.
Kikuchi R, Yasuda Y, Nakatochi M, Shibata Y, Hara T, Suzuki A, Imaizumi T, Suzuki S, Ishii H, Takeshita K, Matsushita T, Maruyama S, Murohara T.
Clin Chim Acta. 2017 Dec;475:102-108.
1 Aging-associated Renal Disease in Mice is Fructokinase Dependent.
Roncal-Jimenez CA, Ishimoto T, Lanaspa MA, Milagres T, Andres-Hernando A, Jensen T, Miyazaki M, Doke T, Hayasaki T, Nakagawa T, Maruyama S, Long DA, Kuwabara M, Sanchez-Lozada LG, Kang DH, Johnson RJ.
Am J Physiol Renal Physiol. 2016 Oct 1; 311(4): F722-F730.
2 Aichi cohort study of the prognosis in patients newly initiated into dialysis (AICOPP): baseline characteristics and trends observed in diabetic nephropathy.
Hishida M, Tamai H, Morinaga T, Maekawa M, Aoki T, Tomida H, Komatsu S, Kamiya T, Maruyama S, Matsuo S, Inaguma D.
Clin Exp Nephrol. 2016 Oct; 20(5): 795-807.
3 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Superimposed on Infection-related Glomerulonephritis Secondary to Pulmonary Mycobacterium avium Complex Infection.
Asano S, Mizuno S, Okachi S, Aso H, Wakahara K, Hashimoto N, Ito S, Kozaki Y, Katsuno T, Maruyama S, Hasegawa Y.
Intern Med. 2016; 55(17): 2439-45.
4 Association between 24h Urinary Sodium and Potassium Excretion and Estimated Glomerular Filtration Rate (eGFR) Decline or Death in Patients with Diabetes Mellitus and eGFR More than 30 ml/min/1.73m2.
Nagata T, Sobajima H, Ohashi N, Hirakawa A, Katsuno T, Yasuda Y, Matsuo S, Tsuboi N, Maruyama S.
PLoS One. 2016 May 2; 11(5):e0152306.
5 Clinical guides for atypical hemolytic uremic syndrome in Japan.
Kato H, Nangaku M, Hataya H, Sawai T, Ashida A, Fujimaru R, Hidaka Y, Kaname S, Maruyama S, Yasuda T, Yoshida Y, Ito S, Hattori M, Miyakawa Y, Fujimura Y, Okada H, Kagami S, Joint Committee for the Revision of Clinical Guides of Atypical Hemolytic Uremic Syndrome in Japan.
Clin Exp Nephrol. 2016 Aug; 20(4): 536-43.
6 Clinical guides for atypical hemolytic uremic syndrome in Japan.
Kato H, Nangaku M, Hataya H, Sawai T, Ashida A, Fujimaru R, Hidaka Y, Kaname S, Maruyama S, Yasuda T, Yoshida Y, Ito S, Hattori M, Miyakawa Y, Fujimura Y, Okada H, Kagami S, Joint Committee for the Revision of Clinical Guides of Atypical Hemolytic Uremic Syndrome in Japan.
Pediatr Int. 2016 Jul; 58(7): 549-55.
7 Comparison of severity classification in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study.
Sada KE, Harigai M, Amano K, Atsumi T, Fujimoto S, Yuzawa Y, Takasaki Y, Banno S, Sugihara T, Kobayashi M, Usui J, Yamagata K, Homma S, Dobashi H, Tsuboi N, Ishizu A, Sugiyama H, Okada Y, Arimura Y, Matsuo S, Makino H; for Research Committee of Intractable Vasculitis Syndrome and Research Committee of Intractable Renal Disease of the Ministry of Health, Labour, and Welfare of Japan.
Mod Rheumatol. 2016 Sep; 26(5): 730-7.
8 Conservation of the Nrf2-Mediated Gene Regulation of Proteasome Subunits and Glucose Metabolism in Zebrafish.
Nguyen VT, Fuse Y, Tamaoki J, Akiyama SI, Muratani M, Tamaru Y, Kobayashi M.
Oxid Med Cell Longev. 2016;2016:5720574.
9 Depression of complement regulatory factors in rat and human renal grafts is associated with the pregress of acute T-cell medicated rejection.
Yamanaka K, Kakuta Y, Miyagawa S, Nakazawa S, Kato T, Abe T, Imamura R, Okumi M, Maeda A, Okuyama H, Mizuno M, Nonomura N.
PLoS One. 2016 Feb 29;11(2):e0148881.
10 Drug-induced kidney disease: a study of the Japan Renal Biopsy Registry from 2007 to 2015.
Yokoyama H, Narita I, Sugiyama H, Nagata M, Sato H, Ueda Y, Matsuo S.
Clin Exp Nephrol. 2016 Oct;20(5):720-730.
11 Effect of dietary energy and polymorphisms in BRAP and GHRL on obesity and metabolic traits.
Imaizumi T, Ando M, Nakatochi M, Yasuda Y, Honda H, Kuwatsuka Y, Kato S, Kondo T, Iwata M, Nakashima T, Yasui H, Takamatsu H, Okajima H, Yoshida Y, Maruyama S.
Obes Res Clin Pract. 2016 May 27. pii: S1871-403X(16)30032-1.
12 Fanconi Syndrome Associated with Hyponatremia in Two Patients with Legionella Pneumonia.
Ryuge A, Ito Y, Yamakawa T, Tanaka H, Yasui H, Mashimo S, Watanabe K, Nomura R, Suganuma N, Maruyama S.
Intern Med. 2016; 55(23):3479-3484.
13 High Ferritin Level and Malnutrition Predict High Risk of Infection-Related Hospitalization in Incident Dialysis Patients: A Japanese Prospective Cohort Study.
Kato S, Lindholm B, Yuzawa Y, Tsuruta Y, Nakauchi K, Yasuda K, Sugiura S, Morozumi K, Tsuboi N, Maruyama S.
Blood Purif. 2016 Apr 20; 42(1):56-63.
14 Identification of C1q as a Binding Protein for Advanced Glycation End Products.
Chikazawa M, Shibata T, Hatasa Y, Hirose S, Otaki N, Nakashima F, Ito M, Machida S, Maruyama S, Uchida K.
Biochemistry. 2016 Jan 26; 55(3): 435-46.
15 Identification of Meflin as a Potential Marker for Mesenchymal Stromal Cells.
Maeda K, Enomoto A, Hara A, Asai N, Kobayashi T, Horinouchi A, Maruyama S, Ishikawa Y, Nishiyama T, Kiyoi H, Kato T, Ando K, Weng L, Mii S, Asai M, Mizutani Y, Watanabe O, Hirooka Y, Goto H, Takahashi M.
Sci Rep. 2016 Feb 29; 6: 22288.
16 Impact of circulating cathepsin K on the coronary calcification and the clinical outcome in chronic kidney disease patients.
Izumi Y, Hayashi M, Morimoto R, Cheng XW, Wu H, Ishii H, Yasuda Y, Yoshikawa D, Izawa H, Matsuo S, Oiso Y, Murohara T.
Heart Vessels. 2016 Jan;31(1):6-14.
17 Impact of non-invasive cardiovascular screening programs as a predictor of cardiovascular events among asymptomatic chronic kidney disease patients.
Sawai A, Yasuda Y, Suzuki S, Ishii H, Goto M, Kato S, Hayashi M, Maruyama S, Murohara T, Oiso Y, Matsuo S.
Clin Exp Nephrol. 2016 Jun;20(3):416-24.
18 In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy.
Serino G, Pesce F, Sallustio F, De Palma G, Cox SN, Curci C, Zaza G, Lai KN, Leung JC, Tang SC, Papagianni A, Stangou M, Goumenos D, Gerolymos M, Takahashi K, Yuzawa Y, Maruyama S, Imai E, Schena FP.
Kidney Int. 2016 Mar;89(3):683-92.
19 Ischemic Acute Tubular Necrosis due to Diltiazem Overdose.
Ryuge A, Shimizu H, Ohyama Y, Yamaguchi M, Nomura A, Maruyama S, Kitamura H, Fujita Y.
Intern Med. 2016; 55(9): 1149-51.
20 Pathological sub-analysis of a multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy versus steroid pulse monotherapy in patients with immunoglobulin A nephropathy.
Katafuchi R, Kawamura T, Joh K, Hashiguchi A, Hisano S, Shimizu A, Miyazaki Y, Nagata M, Matsuo S; IgA nephropathy Study Group in Japan.
Clin Exp Nephrol. 2016 Apr;20(2):244-52.
21 Phospholipase A2 Receptor-Positive Idiopathic Membranous Glomerulonephritis with Onset at 95 Years: Case Report.
Kubota K, Hoshino J, Ueno T, Mise K, Hazue R, Sekine A, Yabuuchi J, Yamanouchi M, Suwabe T, Kikuchi K, Sumida K, Hayami N, Sawa N, Takaichi K, Fujii T, Ohashi K, Akiyama S, Maruyama S, Ubara Y.
Case Rep Nephrol Dial. 2016 May 24; 6(2): 76-82.
22 Presence of Atrial Fibrillation at the Time of Dialysis Initiation Is Associated with Mortality and Cardiovascular Events.
Tanaka A, Inaguma D, Shinjo H, Murata M, Takeda A; Aichi Cohort Study of Prognosis in Patients Newly Initiated into Dialysis (AICOPP) Study Group.
Nephron. 2016;132(2):86-92.
23 Randomized control trial for the assessment of the anti-albuminuric effects of topiroxostat in hyperuricemic patients with diabetic nephropathy (the ETUDE study).
Kato S, Ando M, Mizukoshi T, Nagata T, Katsuno T, Kosugi T, Tsuboi N, Maruyama S.
Nagoya J Med Sci. 2016 May; 78(2): 135-42.
24 Rat Models of Acute and/or Chronic Peritoneal Injuries Including Peritoneal Fibrosis and Peritoneal Dialysis Complications.
Mizuno M, Ito Y.
Methods Mol Biol. 2016; 1397: 35-43.
25 Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).
Imai E, Maruyama S, Nangaku M, Hirakata H, Hayashi T, Narita I, Kono H, Nakatani E, Morita S, Tsubakihara Y, Akizawa T.
Clin Exp Nephrol. 2016 Feb;20(1):71-6.
26 Recent analysis of status and outcomes of peritoneal dialysis in the Tokai area of Japan: the second report of the Tokai peritoneal dialysis registry.
Mizuno M, Ito Y, Suzuki Y, Sakata F, Saka Y, Hiramatsu T, Tamai H, Mizutani M, Naruse T, Ohashi N, Kasuga H, Shimizu H, Kurata H, Kurata K, Suzuki S, Kido S, Tsuruta Y, Matsuoka T, Horie M, Maruyama S, Matsuo S.
Clin Exp Nephrol. 2016 Dec; 20(6): 960-971.
27 Relationship between abdominal aortic and coronary artery calcification as detected by computed tomography in chronic kidney disease patients.
Takayama Y, Yasuda Y, Suzuki S, Shibata Y, Tatami Y, Shibata K, Niwa M, Sawai A, Morimoto R, Kato S, Ishii H, Maruyama S, Murohara T.
Heart Vessels. 2016 Jul; 31(7):1030-7.
28 Telomere Attrition and Elongation after Chronic Dialysis Initiation in Patients with End-Stage Renal Disease.
Kato S, Shiels PG, McGuinness D, Lindholm B, Stenvinkel P, Nordfors L, Qureshi AR, Yuzawa Y, Matsuo S, Maruyama S.
Blood Purif. 2016; 41(1-3):25-33.
29 The effectiveness and safety of modest exercise in Japanese patients with chronic kidney disease: a single-armed interventional study.
Hamada M, Yasuda Y, Kato S, Arafuka H, Goto M, Hayashi M, Kajita E, Maruyama S.
Clin Exp Nephrol. 2016 Apr;20(2):204-11.
30 Transfusion of CD206(+) M2 Macrophages Ameliorates Antibody-Mediated Glomerulonephritis in Mice.
Du Q, Tsuboi N, Shi Y, Ito S, Sugiyama Y, Furuhashi K, Endo N, Kim H, Katsuno T, Akiyama S, Matsuo S, Isobe KI, Maruyama S.
Am J Pathol. 2016 Dec; 186(12):3176-3188.
31 Transition of adolescent and young adult patients with childhood-onset chronic kidney disease from pediatric to adult renal services: a nationwide survey in Japan.
Hattori M, Iwano M, Sako M, Honda M, Okada H, Akioka Y, Ashida A, Kawasaki Y, Kiyomoto H, Terada Y, Hirano D, Fujieda M, Fujimoto S, Masaki T, Maruyama S, Mastuo S.
Clin Exp Nephrol. 2016 Dec; 20(6): 918-925.
32 Urinary Podocalyxin as a Biomarker to Diagnose Membranous Nephropathy.
Imaizumi T, Nakatochi M, Akiyama S, Yamaguchi M, Kurosawa H, Hirayama Y, Katsuno T, Tsuboi N, Hara M, Maruyama S.
PLoS One. 2016 Sep 26; 11(9): e0163507.
33 Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis.
Endo N, Tsuboi N, Furuhashi K, Shi Y, Du Q, Abe T, Hori M, Imaizumi T, Kim H, Katsuno T, Ozaki T, Kosugi T, Matsuo S, Maruyama S.
Nephrol Dial Transplant. 2016 Dec; 31(12): 2023-2033.
34 Vascular Endothelial Cell Injury Is an Important Factor in the Development of Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis Patients.
Tawada M, Ito Y, Hamada C, Honda K, Mizuno M, Suzuki Y, Sakata F, Terabayashi T, Matsukawa Y, Maruyama S, Imai E, Matsuo S, Takei Y.
PLoS One. 2016 Apr 27; 11(4):e0154644.
1 A case of acute renal failure of multiple myeloma due to monoclonal type I cryoglobulinemia with thrombotic microangiopathy.
Okazaki M, Yaomura T, Tsuboi T, Mizuno S, Nakamura T, Hasegawa T, Katayama M, Nakamura H, Iida H, Saito T, Maruyama S, Matsuo S.
CEN Case Rep. 2015 Nov;4(2):174-179.
2 A Prospective Observational Survey on the Long-Term Effect of LDL Apheresis on Drug-Resistant Nephrotic Syndrome.
Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Takemura T, Yuzawa Y, Ogahara S, Sugiyama S, Iino Y, Sakai S, Ogura Y, Yukawa S, Nishizawa Y, Yorioka N, Imai E, Matsuo S, Saito T.
Nephron Extra. 2015 Aug 29;5(2):58-66.
3 Ability of vitamin D receptor activator to prevent pulmonary congestion in advanced chronic kidney disease.
Sueta S, Morozumi K, Takeda A, Horike K, Otsuka Y, Shinjo H, Murata M, Kato Y, Goto K, Inaguma D; Aichi cohort study of prognosis in patients newly initiated into dialysis (AICOPP) study group.
Clin Exp Nephrol. 2015 Jun;19(3):371-8.
4 Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial.
Kato S, Maruyama S, Makino H, Wada J, Ogawa D, Uzu T, Araki H, Koya D, Kanasaki K, Oiso Y, Goto M, Nishiyama A, Kobori H, Imai E, Ando M, Matsuo S.
Clin Exp Nephrol. 2015 Dec;19(6):1098-106.
5 Association of Estimated Glomerular Filtration Rate and Proteinuria With Lipid-Rich Plaque in Coronary Artery Disease.
Shimbo Y, Suzuki S, Ishii H, Shibata Y, Tatami Y, Harata S, Osugi N, Ota T, Tanaka A, Shibata K, Mizukoshi T, Yasuda Y, Maruyama S, Murohara T.
Circ J. 2015;79(10):2263-70.
6 CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cells.
Zhang JM, Murakumo Y, Hagiwara S, Jiang P, Mii S, Kalyoncu E, Saito S, Suzuki C, Sakurai Y, Numata Y, Yamamoto T, Takahashi M.
Biochem Biophys Res Commun. 2015 Apr 3;459(2):252-8.
7 CD147/basigin limits lupus nephritis and Th17 cell differentiation in mice by inhibiting the interleukin-6/STAT-3 pathway.
Maeda K, Kosugi T, Sato W, Kojima H, Sato Y, Kamimura D, Kato N, Tsuboi N, Yuzawa Y, Matsuo S, Murakami M, Maruyama S, Kadomatsu K.
Arthritis Rheumatol. 2015 May;67(8):2185-95.
8 CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpoint.
Kosugi T, Maeda K, Sato W, Maruyama S, Kadomatsu K.
Nephrol Dial Transplant. 2015 Jul;30(7):1097-103.
9 Clinical impact of kidney function on presepsin levels.
Nagata T, Yasuda Y, Ando M, Abe T, Katsuno T, Kato S, Tsuboi N, Matsuo S, Maruyama S.
PLoS One. 2015 Jun 1;10(6):e0129159.
10 Clinical significance of serum and urinary soluble urokinase receptor (suPAR) in primary nephrotic syndrome and MPO-ANCA-associated glomerulonephritis in Japanese.
Fujimoto K, Imura J, Atsumi H, MatsuiY, AdachiH, Okuyama H, Yamaya H, Yokoyama H.
Clin Exp Nephrol. 2015 Oct;19(5):804-14.
11 Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.
Hayashi N, Akiyama S, Okuyama H, Matsui Y, Adachi H, Yamaya H, Maruyama S, Imai E, Matsuo S, Yokoyama H.
Clin Exp Nephrol. 2015 Oct;19(5):797-803.
12 Development and validation of a short-version checklist for patients undergoing hemodialysis based on the International Classification of Functioning, Disability and Health.
Tsutsui H, Ohkubo T, Tsuruta Y, Kato S, Yasuda Y, Oshida Y.
Clin Exp Nephrol. 2015 Oct;19(5):953-60.
13 Effects of serum albumin and glycated albumin levels on performance of the Japanese GFR equation based on serum cystatin C.
Horio M, Imai E, Yasuda Y, Watanabe T, Yokoyama H, Makino H, Matsuo S.
Clin Exp Nephrol. 2015 Aug;19(4):626-30.
14 Efficacy and safety of fluoroscopic manipulation using the alpha-replacer for peritoneal catheter malposition.
Saka Y, Ito Y, Iida Y, Maruyama S, Matsuo S.
Clin Exp Nephrol. 2015 Jun;19(3):521-6.
15 Expression of membrane complement regulators, CD46, CD55 and CD59, in mesothelial cells of patients on peritoneal dialysis therapy.
Sei Y, Mizuno M, Suzuki Y, Imai M, Higashide K, Harris CL, Sakata F, Iguchi D, Fujiwara M, Kodera Y, Maruyama S, Matsuo S, Ito Y.
Mol Immunol. 2015 Jun;65(2):302-9.
16 Functional difference between membrane-bound and soluble human thrombomodulin.
Miwa Y, Yazaki S, Iwamoto M, Suzuki S, Iwasaki K, Haneda M, Yamamoto K, Maruyama S, Onishi A, Kobayashi T.
Transplantation. 2015 Apr;99(4):702-9.
17 Hyperbaric area index calculated from ABPM elucidates the condition of CKD patients: the CKD-JAC study.
Iimuro S, Imai E, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Ohashi Y, Hishida A.
Clin Exp Nephrol. 2015 Feb;19(1):114-24.
18 Identification of an interaction between VWF rs7965413 and platelet count as a novel risk marker for metabolic syndrome: an extensive search of candidate polymorphisms in a case-control study.
Nakatochi M, Ushida Y, Yasuda Y, Yoshida Y, Kawai S, Kato R, Nakashima T, Iwata M, Kuwatsuka Y, Ando M, Hamajima N, Kondo T, Oda H, Hayashi M, Kato S, Yamaguchi M, Maruyama S, Matsuo S, Honda H.
PLoS One. 2015 Feb 3;10(2):e0117591.
19 Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study.
Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Yuzawa Y, Takemura T, Sugiyama S, Nishizawa Y, Ogahara S, Yorioka N, Sakai S, Ogura Y, Yukawa S, Iino Y, Imai E, Matsuo S, Saito T.
Clin Exp Nephrol. 2015 Jun;19(3):379-86.
20 Impact of abdominal aortic calcification on long-term cardiovascular outcomes in patients with chronic kidney disease.
Tatami Y, Yasuda Y, Suzuki S, Ishii H, Sawai A, Shibata Y, Ota T, Shibata K, Niwa M, Morimoto R, Hayashi M, Kato S, Maruyama S, Murohara T.
Atherosclerosis. 2015 Dec; 243(2): 349-55.
21 Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
Yamaguchi M, Ando M, Kato S, Katsuno T, Kato N, Kosugi T, Sato W, Tsuboi N, Yasuda Y, Mizuno M, Ito Y, Matsuo S, Maruyama S.
J Rheumatol. 2015 Oct;42(10):1853-60.
22 Is the new GFR equation using inulin clearance a more accurate method for Asian patients?
Kim BS, Lee YK, Choi HY, Choi SO, Shin SK, Ha SK, Lee KW, Kim YW, Kim YL, Yasuda Y, Imai E, Horio M, Tomino Y, Matsuo S, Lee HY.
Clin Nephrol. 2015 Dec;84(6):331-8.
23 Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
Arai H, Ouchi Y, Toba K, Endo T, Shimokado K, Tsubota K, Matsuo S, Mori H, Yumura W, Yokode M, Rakugi H, Ohshima S.
Geriatr Gerontol Int. 2015 Jun;15(6):673-87.
24 Longitudinal Study of the Decline in Renal Function in Healthy Subjects.
Baba M, Shimbo T, Horio M, Ando M, Yasuda Y, Komatsu Y, Masuda K, Matsuo S, Maruyama S.
PLoS One. 2015 Jun 10;10(6):e0129036.
25 Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids.
Sato Y, Sato W, Maruyama S, Wilcox CS, Falck JR, Masuda T, Kosugi T, Kojima H, Maeda K, Furuhashi K, Ando M, Imai E, Matsuo S, Kadomatsu K.
J Am Soc Nephrol. 2015 Aug;26(8):1806-15.
26 Neutrophil/lymphocyte ratio as a predictor of cardiovascular events in incident dialysis patients: a Japanese prospective cohort study.
Abe T, Kato S, Tsuruta Y, Sugiura S, Katsuno T, Kosugi T, Tsuboi N, Matsuo S, Maruyama S.
Clin Exp Nephrol. 2015 Aug;19(4):718-24.
27 Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Yokoyama H, Sugiyama H, Narita I, Saito T, Yamagata K, Nishio S, Fujimoto S, Mori N, Yuzawa Y, Okuda S, Maruyama S, Sato H, Ueda Y, Makino H, Matsuo S.
Clin Exp Nephrol. 2015 Jun;19(3):496-505.
28 Plasma with high electron density and plasma-activated medium for cancer treatment.
Hiromasa Tanaka, Masaaki Mizuno, Kenji Ishikawa, Hiroki Kondo, Keigo Takeda, Hiroshi Hashizume, Kae Nakamura, Fumi Utsumi, Hiroaki Kajiyama, Hiroyuki Kano, Yasumasa Okazaki, Shinya Toyokuni, Shin’ichi Akiyama, Shoichi Maruyama, Suguru Yamada, Yasuhiro Kodera, Hiroki Kaneko, Hiroko Terasaki, Hirokazu Hara, Tetsuo Adachi, Machiko Iida, Ichiro Yajima, Masashi Kato, Fumitaka Kikkawa, Masaru Hori.
Clinical Plasma Medicine. 2015 Dec;3(2):72–76.
29 Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy.
Akiyama S, Akiyama M, Imai E, Ozaki T, Matsuo S, Maruyama S.
Clin Exp Nephrol. 2015 Aug;19(4):653-60.
30 Primary cilia modulate balance of canonical and non-canonical Wnt signaling responses in the injured kidney.
Saito S, Tampe B, Müller GA, Zeisberg M.
Fibrogenesis Tissue Repair. 2015 Apr 16;8:6.
31 Pulmonary involvements of anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis in Japan.
Hirayama K, Kobayashi M, Usui J, Arimura Y, Sugiyama H, Nitta K, Muso E, Wada T, Matsuo S, Yamagata K; Japanese RPGN Study Group of Progressive Renal Disease.
Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i83-93.
32 Reduction of NO-mediated Relaxing Effects in the Thoracic Aorta in an Experimental Chronic Kidney Disease Mouse Model.
Mori-Kawabe M, Yasuda Y, Ito M, Matsuo S.
J Atheroscler Thromb. 2015 Aug 26;22(8):845-53.
33 Renal function evaluation in patients with cancer who were scheduled to receive carboplatin or S-1.
Shibata K, Yasuda Y, Kobayashi R, Ando Y, Shimokata T, Kamiya H, Hayashi M, Maruyama S, Matsuo S, Nakao M, Tsuchiya T, Teramachi H.
Clin Exp Nephrol. 2015 Dec;19(6):1107-13.
34 Serum albumin, but not glycated albumin was a potent factor affecting the performance of GFR equation based on serum creatinine.
Horio M, Imai E, Yasuda Y, Watanabe T, Yokoyama H, Makino H, Matsuo S.
Clin Exp Nephrol. 2015 Apr;19(2):284-92.
35 The efficacy of tolvaptan as a diuretic for chronic kidney disease patients.
Tanaka A, Katsuno T, Ozaki T, Sakata F, Kato N, Suzuki Y, Kosugi T, Kato S, Tsuboi N, Sato W, Yasuda Y, Mizuno M, Ito Y, Matsuo S, Maruyama S.
Acta Cardiol. 2015 Apr;70(2):217-23.
36 Therapeutic Potential of Stem Cells from Human Exfoliated Deciduous Teeth in Models of Acute Kidney Injury.
Hattori Y, Kim H, Tsuboi N, Yamamoto A, Akiyama S, Shi Y, Katsuno T, Kosugi T, Ueda M, Matsuo S, Maruyama S.
PLoS One. 2015 Oct 28;10(10):e0140121.
37 Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury.
Terabayashi T, Ito Y, Mizuno M, Suzuki Y, Kinashi H, Sakata F, Tomita T, Iguchi D, Tawada M, Nishio R, Maruyama S, Imai E, Matsuo S, Takei Y.
Lab Invest. 2015 Sep;95(9):1029-43.
1 A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease.
Wada T, Nangaku M, Maruyama S, Imai E, Shoji K, Kato S, Endo T, Muso E, Kamata K, Yokoyama H, Fujimoto K, Obata Y, Nishino T, Kato H, Uchida S, Sasatomi Y, Saito T, Matsuo S.
Kidney Int. 2014 Mar;85(3):641-8.
2 A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy.
Kawamura T, Yoshimura M, Miyazaki Y, Okamoto H, Kimura K, Hirano K, Matsushima M, Utsunomiya Y, Ogura M, Yokoo T, Okonogi H, Ishii T, Hamaguchi A, Ueda H, Furusu A, Horikoshi S, Suzuki Y, Shibata T, Yasuda T, Shirai S, Imasawa T, Kanozawa K, Wada A, Yamaji I, Miura N, Imai H, Kasai K, Soma J, Fujimoto S, Matsuo S, Tomino Y; The Special IgA Nephropathy Study Group.
Nephrol Dial Transplant. 2014 Aug;29(8):1546-53.
3 A ray of light in the dark: alternative approaches to the assessment and treatment of ischemic nephropathy.
Tsuboi N, Maruyama S, Matsuo S, Imai E.
Nephrol Dial Transplant. 2014 Feb;29(2):228-31.
4 Anti-neutrophil cytoplasmic antibody-associated vasculitis associated with infectious mononucleosis due to primary Epstein-Barr virus infection: report of three cases.
Yamaguchi M, Yoshioka T, Yamakawa T, Maeda M, Shimizu H, Fujita Y, Maruyama S, Ito Y, Matsuo S.
Clin Kidney J. 2014 Feb;7(1):45-8.
5 Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Melo SA, Sugimoto H, O'Connell JT, Kato N, Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, Lucci A, Ivan C, Calin GA, Kalluri R.
Cancer Cell. 2014 Nov 10;26(5):707-21.
6 CD147/basigin reflects renal dysfunction in patients with acute kidney injury.
Nagaya H, Kosugi T, Maeda-Hori M, Maeda K, Sato Y, Kojima H, Hayashi H, Kato N, Ishimoto T, Sato W, Yuzawa Y, Matsuo S, Kadomatsu K, Maruyama S.
Clin Exp Nephrol. 2014 Oct;18(5):746-54.
7 Comparison of kidney disease: improving global outcomes and acute kidney injury network criteria for assessing patients in intensive care units.
Shinjo H, Sato W, Imai E, Kosugi T, Hayashi H, Nishimura K, Nishiwaki K, Yuzawa Y, Matsuo S, Maruyama S.
Clin Exp Nephrol. 2014 Oct;18(5):737-45.
8 Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan.
Furuta S, Chaudhry AN, Hamano Y, Fujimoto S, Nagafuchi H, Makino H, Matsuo S, Ozaki S, Endo T, Muso E, Ito C, Kusano E, Yamagata M, Ikeda K, Kashiwakuma D, Iwamoto I, Westman K, Jayne D.
J Rheumatol. 2014 Feb;41(2):325-33.
9 Geriatric nutritional risk index accurately predicts cardiovascular mortality in incident hemodialysis patients.
Takahashi H, Ito Y, Ishii H, Aoyama T, Kamoi D, Kasuga H, Yasuda K, Maruyama S, Matsuo S, Murohara T, Yuzawa Y.
J Cardiol. 2014 Jul;64(1):32-6.
10 Impact of albuminuria on the incidence of periprocedural myocardial injury in patients undergoing elective coronary stent implantation.
Osugi N, Suzuki S, Ishii H, Yasuda Y, Shibata Y, Tatami Y, Ota T, Kawamura Y, Okumura S, Tanaka A, Inoue Y, Matsuo S, Murohara T.
Am J Cardiol. 2014 Jul 1;114(1):42-6.
11 Long-term effects of spironolactone in peritoneal dialysis patients.
Ito Y, Mizuno M, Suzuki Y, Tamai H, Hiramatsu T, Ohashi H, Ito I, Kasuga H, Horie M, Maruyama S, Yuzawa Y, Matsubara T, Matsuo S, Nagoya Spiro Study G.
J Am Soc Nephrol. 2014 May;25(5):1094-102.
12 Lower serum albumin level is associated with higher fractional excretion of creatinine.
Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S.
Clin Exp Nephrol. 2014 Jun;18(3):469-74.
13 Lysine pyrrolation is a naturally-occurring covalent modification involved in the production of DNA mimic proteins.
Miyashita H, Chikazawa M, Otaki N, Hioki Y, Shimozu Y, Nakashima F, Shibata T, Hagihara Y, Maruyama S, Matsumi N, Uchida K.
Sci Rep. 2014 Jun 18;4:5343.
14 Novel preprocedural and acute-phase postprocedural predictive factors for contrast-induced kidney injury in CKD patients.
Okumura N, Hayashi M, Ishii H, Yoshikawa D, Yasuda Y, Goto M, Matsuo S, Oiso Y, Murohara T.
Int J Cardiol. 2014 Mar 15;172(2):e293-6.
15 Overestimation of the risk of progression to end-stage renal disease in the poor prognosis' group according to the 2002 Japanese histological classification for immunoglobulin A nephropathy.
Miyazaki Y, Kawamura T, Joh K, Okonogi H, Koike K, Utsunomiya Y, Ogura M, Matsushima M, Yoshimura M, Horikoshi S, Suzuki Y, Furusu A, Yasuda T, Shirai S, Shibata T, Endoh M, Hattori M, Akioka Y, Katafuti R, Hashiguchi A, Kimura K, Matsuo S, Tomino Y.
Clin Exp Nephrol. 2014 Jun;18(3):475-80.
16 Patient age and the prognosis of idiopathic membranous nephropathy.
Yamaguchi M, Ando M, Yamamoto R, Akiyama S, Kato S, Katsuno T, Kosugi T, Sato W, Tsuboi N, Yasuda Y, Mizuno M, Ito Y, Matsuo S, Maruyama S.
PLoS One, 2014 Oct 20;9(10):e110376.
17 Plasma CD147 reflects histological features in patients with lupus nephritis.
Maeda-Hori M, Kosugi T, Kojima H, Sato W, Inaba S, Maeda K, Nagaya H, Sato Y, Ishimoto T, Ozaki T, Tsuboi N, Muro Y, Yuzawa Y, Imai E, Johnson RJ, Matsuo S, Kadomatsu K, Maruyama S.
Lupus. 2014 Apr;23(4):342-52.
18 Plasma Medical Science for Cancer Therapy:Toward Cancer Therapy Using Nonthermal Atmospheric Pressure Plasma.
Hiromasa Tanaka, Masaaki Mizuno, Kenji Ishikawa, Keigo Takeda, Kae Nakamura, Fumi Utsumi, Hiroaki Kajiyama, Hiroyuki Kano, Yasumasa Okazaki, Shinnya Toyokuni, Shoichi Maruyama, Fumitaka Kikkawa, and Masaru Hori
IEEE T Plasma Sci. 2014 Nov;42(12):3760-4.
19 Pristane-induced granulocyte recruitment promotes phenotypic conversion of macrophages and protects against diffuse pulmonary hemorrhage in Mac-1 deficiency.
Shi Y, Tsuboi N, Furuhashi K, Du Q, Horinouchi A, Maeda K, Kosugi T, Matsuo S, Maruyama S.
J Immunol. 2014 Nov 15;193(10):5129-39.
20 Proposal of remission criteria for IgA nephropathy.
Suzuki Y, Matsuzaki K, Suzuki H, Sakamoto N, Joh K, Kawamura T, Tomino Y, Matsuo S.
Clin Exp Nephrol. 2014 Jun;18(3):481-6.
21 Rat adipose tissue-derived stem cells attenuate peritoneal injuries in rat zymosan-induced peritonitis accompanied by complement activation.
Kim H, Mizuno M, Furuhashi K, Katsuno T, Ozaki T, Yasuda K, Tsuboi N, Sato W, Suzuki Y, Matsuo S, Ito Y, Maruyama S.
Cytotherapy, 2014 Mar;16(3):357-68.
22 Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial.
Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Shuto H, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y; Refractory Nephrotic Syndrome Study Group.
Clin Exp Nephrol. 2014 Oct;18(5):784-94.
23 Smoking is a risk factor for the progression of idiopathic membranous nephropathy.
Yamaguchi M, Ando M, Yamamoto R, Akiyama S, Kato S, Katsuno T, Kosugi T, Sato W, Tsuboi N, Yasuda Y, Mizuno M, Ito Y, Matsuo S, Maruyama S.
PLoS One. 2014 Jun 25;9(6):e100835.
24 Taming the chronic kidney disease epidemic: a global view of surveillance efforts.
Radhakrishnan J, Remuzzi G, Saran R, Williams DE, Rios-Burrows N, Powe N; for the CDC-CKD Surveillance Team, Brück K, Wanner C, Stel VS; on behalf of the European CKD Burden Consortium, Venuthurupalli SK, Hoy WE, Healy HG, Salisbury A, Fassett RG; on behalf of the CKD.QLD group, O'Donoghue D, Roderick P, Matsuo S, Hishida A, Imai E, Iimuro S.
Kidney Int. 2014 Aug;86(2):246-50.
25 The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study.
Hosoya T, Kimura K, Itoh S, Inaba M, Uchida S, Tomino Y, Makino H, Matsuo S, Yamamoto T, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H.
Trials. 2014 Jan 16;15:26.
26 Validity of a checklist for hemodialysis patients based on the International Classification Of Functioning, Disability and Health.
Tsutsui H, Ojima T, Tsuruta Y, Kato S, Yasuda Y, Oshida Y.
Ther Apher Dial. 2014 Oct;18(5):473-80.
1 A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.
Kawamura T, Joh K, Okonogi H, Koike K, Utsunomiya Y, Miyazaki Y, Matsushima M, Yoshimura M, Horikoshi S, Suzuki Y, Furusu A, Yasuda T, Shirai S, Shibata T, Endoh M, Hattori M, Akioka Y, Katafuchi R, Hashiguchi A, Kimura K, Matsuo S, Tomino Y, Study Group SI.
J Nephrol. 2013 Mar-Apr;26(2):350-7.
2 Anti-C5a complementary peptide ameliorates acute peritoneal injury induced by neutralization of Crry and CD59.
Mizuno T, Mizuno M, Imai M, Suzuki Y, Kushida M, Noda Y, Maruyama S, Okada H, Okada N, Matsuo S, Ito Y.
Am J Physiol Renal Physiol. 2013 Dec 1;305(11):F1603-16.
3 Association of cardiac valvular calcifications and C-reactive protein with cardiovascular mortality in incident hemodialysis patients: a Japanese cohort study.
Takahashi H, Ishii H, Aoyama T, Kamoi D, Kasuga H, Ito Y, Yasuda K, Tanaka M, Yoshikawa D, Maruyama S, Matsuo S, Murohara T, Yuzawa Y.
Am J Kidney Dis. 2013 Feb;61(2):254-61.
4 Clinical Correlates of Ambulatory BP Monitoring among Patients with CKD.
Iimuro S, Imai E, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Ohashi Y, Hishida A; for the Chronic Kidney Disease Japan Cohort Study Group.
Clin J Am Soc Nephrol. 2013 May;8(5):721-30.
5 Clinical findings on ANCA-associated renal vasculitis from the Japan RPGN registry obtained via a questionnaire survey.
Yamagata K, Usui J, Sugiyama H, Nitta K, Wada T, Muso E, Arimura Y, Koyama A, Makino H, Matsuo S.
Clin Exp Nephrol. 2013 Oct;17(5):646-649.
6 Deficiency of growth factor midkine exacerbates necrotizing glomerular injuries in progressive glomerulonephritis.
Kojima H, Kosugi T, Sato W, Sato Y, Maeda K, Kato N, Kato K, Inaba S, Ishimoto T, Tsuboi N, Matsuo S, Maruyama S, Yuzawa Y, Kadomatsu K.
Am J Pathol. 2013 Feb;182(2):410-9.
7 Distribution of hydrogen sulfide (H(2)S)-producing enzymes and the roles of the H(2)S donor sodium hydrosulfide in diabetic nephropathy.
Yamamoto J, Sato W, Kosugi T, Yamamoto T, Kimura T, Taniguchi S, Kojima H, Maruyama S, Imai E, Matsuo S, Yuzawa Y, Niki I.
Clin Exp Nephrol, 2013 Feb;17(1):32-40.
8 Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome.
Lanaspa MA, Ishimoto T, Li N, Cicerchi C, Orlicky DJ, Ruzycki P, Rivard C, Inaba S, Roncal-Jimenez CA, Bales ES, Diggle CP, Asipu A, Petrash JM, Kosugi T, Maruyama S, Sanchez-Lozada LG, McManaman JL, Bonthron DT, Sautin YY, Johnson RJ.
Nat Commun. 2013;4:2434.
9 Establishment of mouse model of MYH9 disorders: heterozygous R702C mutation provokes macrothrombocytopenia with leukocyte inclusion bodies, renal glomerulosclerosis and hearing disability.
Suzuki N, Kunishima S, Ikejiri M, Maruyama S, Sone M, Takagi A, Ikawa M, Okabe M, Kojima T, Saito H, Naoe T, Matsushita T.
PLoS One. 2013 Aug 20;8(8):e71187.
10 GFR Estimation Using Standardized Serum Cystatin C in Japan.
Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S; Collaborators Developing the Japanese Equation for Estimated GFR.
Am J Kidney Dis. 2013 Feb;61(2):197-203.
11 High-Fat and High-Sucrose (Western) Diet Induces Steatohepatitis That Is Dependent on Fructokinase.
Ishimoto T, Lanaspa MA, Rivard CJ, Roncal-Jimenez CA, Orlicky DJ, Cicerchi C, McMahan RH, Abdelmalek MF, Rosen HR, Jackman MR, MacLean PS, Diggle CP, Asipu A, Inaba S, Kosugi T, Sato W, Maruyama S, Sánchez-Lozada LG, Sautin YY, Hill JO, Bonthron DT, Johnson RJ.
Hepatology. 2013 Nov;58(5):1632-43.
12 Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010.
Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, Tsuruya K, Kiyomoto H, Iida H, Sasaki T, Higuchi M, Hattori M, Oka K, Kagami S, Kawamura T, Takeda T, Hataya H, Fukasawa Y, Fukatsu A, Morozumi K, Yoshikawa N, Shimizu A, Kitamura H, Yuzawa Y, Matsuo S, Kiyohara Y, Joh K, Nagata M, Taguchi T, Makino H; Committee for Standardization of Renal Pathological Diagnosis and Committee for Kidney Disease Registry, Japanese Society of Nephrology, Japan.
Clin Exp Nephrol. 2013 Apr;17(2):155-73.
13 Low serum cultured adipose tissue-derived stromal cells ameliorate acute kidney injury in rats.
Katsuno T, Ozaki T, Saka Y, Furuhashi K, Kim H, Yasuda K, Yamamoto T, Sato W, Tsuboi N, Mizuno M, Ito Y, Imai E, Matsuo S, Maruyama S.
Cell Transplant. 2013;22(2):287-97.
14 Minimal change disease in graft versus host disease: a podocyte response to the graft?
Huskey J, Rivard C, Myint H, Lucia S, Smith M, Shimada M, Ishimoto T, Araya C, Garin EH, Johnson RJ.
Clin Nephrol. 2013 Dec;80(6):469-73.
15 Multispecificity of immunoglobulin M antibodies raised against advanced glycation end products: involvement of electronegative potential of antigens.
Chikazawa M, Otaki N, Shibata T, Miyashita H, Kawai Y, Maruyama S, Toyokuni S, Kitaura Y, Matsuda T, Uchida K.
J Biol Chem. 2013 May 10;288(19):13204-14.
16 Nationwide survey on current treatments for IgA nephropathy in Japan.
Matsuzaki K, Suzuki Y, Nakata J, Sakamoto N, Horikoshi S, Kawamura T, Matsuo S, Tomino Y.
Clin Exp Nephrol. 2013 Dec;17(6):827-33.
17 Perforative peritonitis caused by appendicitis in a patient on peritoneal dialysis.
Mizuno M, Suzuki Y, Nonaka K, Sei Y, Maruyama S, Matsuo S, Ito Y.
Intern Med. 2013;52(11):1177-81.
18 Performance of the Japanese GFR equation in potential kidney donors.
Horio M, Yasuda Y, Kaimori J, Ichimaru N, Isaka Y, Takahara S, Nishi S, Uchida K, Takeda A, Hattori R, Kitada H, Tsuruya K, Imai E, Takahashi K, Watanabe T, Matsuo S.
Clin Exp Nephrol. 2013 Jun;17(3):352-8.
19 [Progressive renal diseases: recent advances in diagnosis and treatments. Topics: I. Diagnosis; 4. Nephrotic syndrome].
Maruyama S.
Nihon Naika Gakkai Zasshi. 2013 May 10;102(5):1098-104.
20 Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease.
Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A.
Clin Exp Nephrol. 2013 Oct;17(5):730-742.
21 Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages.
Furuhashi K, Tsuboi N, Shimizu A, Katsuno T, Kim H, Saka Y, Ozaki T, Sado Y, Imai E, Matsuo S, Maruyama S.
J Am Soc Nephrol. 2013 Mar;24(4):587-603.
22 TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis.
Kinashi H1, Ito Y, Mizuno M, Suzuki Y, Terabayashi T, Nagura F, Hattori R, Matsukawa Y, Mizuno T, Noda Y, Nishimura H, Nishio R, Maruyama S, Imai E, Matsuo S, Takei Y.
J Am Soc Nephrol. 2013 Oct;24(10):1627-42.
23 Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice.
Ishimoto T, Shimada M, Gabriela G, Kosugi T, Sato W, Lee PY, Lanaspa MA, Rivard C, Maruyama S, Garin EH, Johnson RJ.
Nephrol Dial Transplant. 2013 Jun;28(6):1439-46.
24 Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevity.
Benigni A, Orisio S, Noris M, Iatropoulos P, Castaldi D, Kamide K, Rakugi H, Arai Y, Todeschini M, Ogliari G, Imai E, Gondo Y, Hirose N, Mari D, Remuzzi G.
Age (Dordr). 2013 Jun;35(3):993-1005.
1 A candidate gene approach to genetic contributors to the development of IgA nephropathy.
Yamamoto R, Nagasawa Y, Shoji T, Katakami N, Ohtoshi K, Hayaishi-Okano R, Yamasaki Y, Yamauchi A, Tsubakihara Y, Imai E, Rakugi H, Isaka Y.
Nephrol Dial Transplant. 2012 Mar;27(3):1020-30.
2 A Decade After the KDOQI CKD Guidelines: A Perspective From Japan.
Imai E, Yasuda Y, Matsuo S.
Am J Kidney Dis. 2012 Nov;60(5):729-30.
3 A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin.
Ito I, Ito Y, Mizuno M, Suzuki Y, Yasuda K, Ozaki T, Kosugi T, Yasuda Y, Sato W, Tsuboi N, Maruyama S, Imai E, Matsuo S.
Clin Exp Nephrol, 2012 Jun;16(3):490-4.
4 Aliskiren-induced chyloperitoneum in a patient on peritoneal dialysis.
Saka Y, Tachi H, Sakurai H, Tawada M, Sawai A, Shimamura Y, Mizuno M, Maruyama S, Matsuo S, Ito Y.
Perit Dial Int. 2012 Jan-Feb;32(1):111-3.
5 ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes.
Yamagata K, Usui J, Saito C, Yamaguchi N, Hirayama K, Mase K, Kobayashi M, Koyama A, Sugiyama H, Nitta K, Wada T, Muso E, Arimura Y, Makino H, Matsuo S.
Clin Exp Nephrol. 2012 Aug;16(4):580-8.
6 Asymptomatic diverticulosis identified by computed tomography is not a risk factor for enteric peritonitis.
Toda S, Ito Y, Mizuno M, Suzuki Y, Ito I, Hiramatsu H, Ozaki T, Tsuboi N, Sato W, Maruyama S, Imai E, Matsuo S.
Nephrol Dial Transplant. 2012 Jun;27(6):2511-6.
7 Atelocollagen-mediated systemic delivery prevents immunostimulatory adverse effects of siRNA in mammals.
Inaba S, Nagahara S, Makita N, Tarumi Y, Ishimoto T, Matsuo S, Kadomatsu K, Takei Y.
Mol Ther. 2012 Feb;20(2):356-66.
8 Atrial natriuretic peptide ameliorates peritoneal fibrosis in rat peritonitis model.
Kato H, Mizuno T, Mizuno M, Sawai A, Suzuki Y, Kinashi H, Nagura F, Maruyama S, Noda Y, Yamada K, Matsuo S, Ito Y.
Nephrol Dial Transplant. 2012 Feb;27(2):526-36.
9 Autologous cell therapy for cisplatin-induced acute kidney injury by using non-expanded adipose tissue-derived cells.
Yasuda K, Ozaki T, Saka Y, Yamamoto T, Gotoh M, Ito Y, Yuzawa Y, Matsuo S, Maruyama S.
Cytotherapy. 2012; 14: 1089-1100.
10 Combined values of serum albumin, C-reactive protein and body mass index at dialysis initiation accurately predicts long-term mortality.
Takahashi R, Ito Y, Takahashi H, Ishii H, Kasuga H, Mizuno M, Suzuki Y, Yuzawa Y, Maruyama S, Murohara T, Imai E, Matsuo S.
Am J Nephrol. 2012; 36: 136-143.
11 Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy.
Tatematsu M, Yasuda Y, Morita Y, Sakamoto I, Kurata K, Naruse T, Yamamoto R, Tsuboi N, Sato W, Imai E, Matsuo S, Maruyama S.
Clin Exp Nephrol. 2012; 16: 883-891.
12 Continuous positive airway pressure intolerance associated with elevated nasal resistance is possible mechanism of complex sleep apnea syndrome.
Nakazaki C, Noda A, Yasuda Y, Nakata S, Koike Y, Yasuma F, Murohara T, Nakashima T.
Sleep Breath. 2012 Sep;16(3):747-52.
13 DNA hypermethylation and inflammatory markers in incident Japanese dialysis patients.
Kato S, Lindholm B, Stenvinkel P, Ekstrom TJ, Luttropp K, Yuzawa Y, Yasuda Y, Tsuruta Y, Maruyama S.
Nephron Extra. Jan;2(1):159-68.
14 Effects of carperitide on contrast-induced acute kidney injury with a minimum volume of contrast in chronic kidney disease patients.
Okumura N, Hayashi M, Imai E, Ishii H, Yoshikawa D, Yasuda Y, Goto M, Matsuo S, Oiso Y, Murohara T.
Nephron Extra. 2012 Jan;2(1):303-10.
15 Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis.
Nishiwaki S, Nakayama T, Saito S, Mizuno H, Ozaki T, Takahashi Y, Maruyama S, Nishida T, Murata M, Kojima S, Naoe T.
Int J Hematol. 2012 Sep;96(3):295-300.
16 Endocytosis of soluble immune complexes leads to their clearance by FcγRIIIB but induces neutrophil extracellular traps via FcγRIIA in vivo.
Chen K, Nishi H, Travers R, Tsuboi N, Martinod K, Wagner DD, Stan R, Croce K, Mayadas TN.
Blood. 2012 Nov 22;120(22):4421-31.
17 Endothelial CD47 Promotes Vascular Endothelial-Cadherin Tyrosine Phosphorylation and Participates in T Cell Recruitment at Sites of Inflammation In Vivo.
Azcutia V, Stefanidakis M, Tsuboi N, Mayadas T, Croce KJ, Fukuda D, Aikawa M, Newton G, Luscinskas FW.
J Immunol. 2012 Sep 1;189(5):2553-62.
18 Ethnic factors of the glomerular filtration rate estimating equation.
Horio M, Yasuda Y, Imai E.
Kidney Int. 2012 Apr;81(8):799.
19 Exploiting the Nephrotoxic Effects of Venom from the Sea Anemone, Phyllodiscus semoni, to Create a Hemolytic Uremic Syndrome Model in the Rat.
Mizuno M, Ito Y, Morgan BP.
Mar Drugs. 2012 Jul;10(7):1582-604.
20 Functional consequences of inhibiting exocytosis of Weibel-Palade bodies in acute renal ischemia.
Yasuda K, Vasko R, Hayek P, Ratliff B, Bicer H, Mares J, Maruyama S, Bertuglia S, Mascagni P, Goligorsky MS.
Am J Physiol Renal Physiol. 2012 Mar 15;302(6):F713-21.
21 Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy.
Shinzawa M, Yamamoto R, Nagasawa Y, Shoji T, Obi Y, Namba T, Kitamura H, Kaneko T, Okada N, Iwatani H, Yamauchi A, Tsubakihara Y, Imai E, Isaka Y, Rakugi H.
Clin Exp Nephrol. 2012 Apr;16(2):250-8.
22 Glomerular hyperfiltration in prediabetes and prehypertension.
Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S.
Nephrol Dial Transplant. 2012; 27: 1821-1825.
23 Guideline for hereditary angioedema (HAE) 2010 by the Japanese Association for Complement Research - secondary publication.
Horiuchi T, Ohi H, Ohsawa I, Fujita T, Matsushita M, Okada N, Seya T, Yamamoto T, Endo Y, Hatanaka M, Wakamiya N, Mizuno M, Nakao M, Okada H, Tsukamoto H, Matsumoto M, Inoue N, Nonaka M, Kinoshita T; Japanese Association for Complement Research.
Allergol Int. 2012 Dec;61(4):559-62.
24 Human Lupus Serum Induces Neutrophil-Mediated Organ Damage in Mice That Is Enabled by Mac-1 Deficiency.
Rosetti F, Tsuboi N, Chen K, Nishi H, Ernandez T, Sethi S, Croce K, Stavrakis G, Alcocer-Varela J, Gómez-Martin D, van Rooijen N, Kyttaris VC, Lichtman AH, Tsokos GC, Mayadas TN.
J Immunol. 2012 Oct 1;189(7):3714-23.
25 Impact of diabetes and glycaemic control on peripheral artery disease in Japanese patients with end-stage renal disease: long-term follow-up study from the beginning of haemodialysis.
Ishii H, Kumada Y, Takahashi H, Toriyama T, Aoyama T, Tanaka M, Yoshikawa D, Hayashi M, Kasuga H, Yasuda Y, Maruyama S, Matsubara T, Matsuo S, Murohara T.
Diabetologia. 2012; 55: 1304-1309.
26 KDIGO (Kidney Disease: Improving Global Outcomes) Criteria Could Be a Useful Outcome Predictor of Cisplatin-Induced Acute Kidney Injury.
Mizuno T, Sato W, Ishikawa K, Shinjo H, Miyagawa Y, Noda Y, Imai E, Yamada K.
Oncology. 2012;82(6):354-9.
27 Membrane complement regulators protect against fibrin exudation increases in a severe peritoneal inflammation model in rats.
Mizuno M, Ito Y, Mizuno T, Harris CL, Suzuki Y, Okada N, Matsuo S, Morgan BP.
Am J Physiol Renal Physiol. 2012 May 15;302(10):F1245-51.
28 Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy.
Hirayama A, Nakashima E, Sugimoto M, Akiyama SI, Sato W, Maruyama S, Matsuo S, Tomita M, Yuzawa Y, Soga T.
Anal Bioanal Chem. 2012 Dec;404(10):3101-9.
29 microRNA-Induced IgA Nephropathy.
Imai E, Maruyama S.
J Am Soc Nephrol. 2012 May;23(5):765-6.
30 Midkine and the kidney: health and diseases.
Kosugi T, Sato W.
Nephrol Dial Transplant. 2012 Jan;27(1):16-21.
31 Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice.
Ishimoto T, Lanaspa MA, Le MT, Garcia GE, Diggle CP, Maclean PS, Jackman MR, Asipu A, Roncal-Jimenez CA, Kosugi T, Rivard CJ, Maruyama S, Rodriguez-Iturbe B, Sánchez-Lozada LG, Bonthron DT, Sautin YY, Johnson RJ.
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4320-5.
32 Percutaneous coronary intervention with bare metal stent vs. drug-eluting stent in hemodialysis patients.
Ishii H, Toriyama T, Aoyama T, Takahashi H, Tanaka M, Yoshikawa D, Hayashi M, Yasuda Y, Maruyama S, Matsuo S, Matsubara T, Murohara T.
Circ J. 2012; 76: 1609-1615.
33 Performance of GFR equations in Japanese subjects.
Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S.
Diabet Med. 2007 Dec;24(12):1482-6.
34 Pharmacokinetic study of S-1 in patients in whom inulin clearance was measured.
Ando Y, Kawada K, Inada M, Morita S, Mitsuma A, Yasuda Y, Hiramatsu M, Fujimoto Y, Fujita K.
Oncology. 2012;83(1):38-44.
35 Production of cloned pigs expressing human thrombomodulin in endothelial cells.
Yazaki S, Iwamoto M, Onishi A, Miwa Y, Hashimoto M, Oishi T, Suzuki S, Fuchimoto D, Sembon S, Furusawa T, Liu D, Nagasaka T, Kuzuya T, Ogawa H, Yamamoto K, Iwasaki K, Haneda M, Maruyama S, Kobayashi T.
Xenotransplantation. 2012 Mar-Apr;19(2):82-91.
36 Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR).
Yokoyama H, Sugiyama H, Sato H, Taguchi T, Nagata M, Matsuo S, Makino H, Watanabe T, Saito T, Kiyohara Y, Nishi S, Iida H, Morozumi K, Fukatsu A, Sasaki T, Tsuruya K, Kohda Y, Higuchi M, Kiyomoto H, Goto S, Hattori M, Hataya H, Kagami S, Yoshikawa N, Fukasawa Y, Ueda Y, Kitamura H, Shimizu A, Oka K, Nakagawa N, Ito T, Uchida S, Furuichi K, Nakaya I, Umemura S, Hiromura K, Yoshimura M, Hirawa N, Shigematsu T, Fukagawa M, Hiramatsu M, Terada Y, Uemura O, Kawata T, Matsunaga A, Kuroki A, Mori Y, Mitsuiki K, Yoshida H.
Clin Exp Nephrol. 2012 Dec;16(6):903-20.
37 Renal impairment after laparoscopic radical nephrectomy affects hypoglycemic therapy.
Mizuno T, Ito K, Miyagawa Y, Kimura K, Suzuki Y, Mizuno M, Ito Y, Funahashi Y, Nodashi Y, Hattori R, Gotoh M, Yamada K.
J Clin Pharm Ther. 2012 Feb;37(1):49-52.
38 RET finger protein expression is associated with prognosis in lung cancer with epidermal growth factor receptor mutations.
Iwakoshi A, Murakumo Y, Kato T, Kitamura A, Mii S, Saito S, Yatabe Y, Takahashi M.
Pathol Int. 2012 May;62(5):324-30.
39 Short-term administration of diclofenac sodium affects renal function after laparoscopic radical nephrectomy in elderly patients.
Mizuno T, Ito K, Miyagawa Y, Ishikawa K, Suzuki Y, Mizuno M, Ito Y, Funahashi Y, Hattori R, Gotoh M, Yamada K, Noda Y.
Jpn J Clin Oncol. 2012 Nov;42(11):1073-8.
40 Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway.
Shimada M, Ishimoto T, Lee PY, Lanaspa MA, Rivard CJ, Roncal-Jimenez CA, Wymer DT, Yamabe H, Mathieson PW, Saleem MA, Garin EH, Johnson RJ.
Nephrol Dial Transplant. 2012 Jan;27(1):81-9.
41 Towards developing new strategies to reduce the adverse side-effects of nonsteroidal anti-inflammatory drugs.
Kawada N, Moriyama T, Kitamura H, Yamamoto R, Furumatsu Y, Matsui I, Takabatake Y, Nagasawa Y, Imai E, Wilcox CS, Rakugi H, Isaka Y.
Clin Exp Nephrol. 2012 Feb;16(1):25-9.
42 Transforming growth factor-beta induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction.
Suzuki Y, Ito Y, Mizuno M, Kinashi H, Sawai A, Noda Y, Mizuno T, Shimizu H, Fujita Y, Matsui K, Maruyama S, Imai E, Matsuo S, Takei Y.
Kidney Int. 2012; 81: 865-879.
43 Uric acid induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress: Potential Role in Fructose-Dependent and-Independent Fatty Liver.
Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M, Roncal-Jimenez CA, Ishimoto T, Li N, Marek G, Duranay M, Schreiner G, Rodriguez-Iturbe B, Nakagawa T, Kang DH, Sautin YY, Johnson RJ.
J Biol Chem. 2012 Nov 23;287(48):40732-44.
1 A case of acute renal failure caused by cholesterol embolization after carotid artery stenting that was improved by peritoneal dialysis.
Mizuno M, Ito Y, Hayasaki T, Suzuki Y, Hiramatsu H, Toda S, Mizuno T, Tatematsu M, Ozaki T, Yasuda Y, Sato W, Tsuboi N, Ito I, Maruyama S, Imai E, Matsuo S.
Intern Med. 2011; 50: 1719-1723.
2 A case of fulminant peritonitis caused by Streptococcus mitis in a patient on peritoneal dialysis.
Mizuno M, Ito Y, Masuda T, Toda S, Hiramatsu H, Suzuki Y, Ozaki T, Yasuda Y, Ito I, Tsuboi N, Sato W, Maruyama S, Imai E, Matsuo S.
Intern Med. 2011; 50: 471-474.
3 A case of perforative peritonitis caused by a piece of bamboo in a patient on peritoneal dialysis.
Suzuki Y, Mizuno M, Nakashima R, Hiramatsu H, Toda S, Sato W, Tsuboi N, Ito I, Maruyama S, Imai E, Matsuo S, Ito Y.
Clin Exp Nephrol. 2011; 15: 962-965.
4 A superagonistic monoclonal antibody for CD28 ameliorates crescentic glomerulonephritis in Wistar-Kyoto rats.
Takabatake Y, Li XK, Mizui M, Miyasato K, Matsui I, Kawada N, Imai E, Nig TH, Takahara S, Wada T, Furuichi K, Rakugi H, Isaka Y.
Mol Med. 2011;17(7-8):686-96.
5 Adipose-derived stromal cells cultured in a low-serum medium, but not bone marrow-derived stromal cells, impede xenoantibody production.
Saka Y, Furuhashi K, Katsuno T, Kim H, Ozaki T, Iwasaki K, Haneda M, Sato W, Tsuboi N, Ito Y, Matsuo S, Kobayashi T, Maruyama S.
Xenotransplantation. 2011; 18: 196-208.
6 Analysis of glial cell line-derived neurotrophic factor-inducible zinc finger protein 1 expression in human diseased kidney.
Saito S, Murakumo Y, Tsuzuki T, Dambara A, Kato T, Enomoto A, Asai N, Maruyama S, Matsuo S, Takahashi M.
Hum Pathol. 2011; 42: 848-858.
7 Asian Chronic Kidney Disease (CKD) Best Practice Recommendations - Positional Statements for Early Detection of CKD from Asian Forum for CKD Initiatives (AFCKDI).
Li PK, Chow KM, Matsuo S, Yang CW, Jha V, Becker G, Chen N, Sharma SK, Chittinandana A, Chowdhury S, Harris DC, Hooi LS, Imai E, Kim S, Kim SG, Langham R, Padilla BS, Teo BW, Togtokh A, Walker RG, Wang HY, Tsukamoto Y.
Nephrology (Carlton). 2011 Sep;16(7):633-41.
8 Association of Adiponectin with Carotid Arteriosclerosis in Predialysis Chronic Kidney Disease.
Hayashi M, Shibata R, Takahashi H, Ishii H, Aoyama T, Kasuga H, Yamada S, Ohashi K, Maruyama S, Matsuo S, Ouchi N, Murohara T, Toriyama T.
Am J Nephrol. 2011;34(3):249-55.
9 Basigin/CD147 promotes renal fibrosis after unilateral ureteral obstruction.
Kato N, Kosugi T, Sato W, Ishimoto T, Kojima H, Sato Y, Sakamoto K, Maruyama S, Yuzawa Y, Matsuo S, Kadomatsu K.
Am J Pathol. 2011; 178: 572-579.
10 Effects of chronic kidney disease and post-angiographic acute kidney injury on long-term prognosis after coronary artery angiography.
Kimura T, Obi Y, Yasuda K, Sasaki K, Takeda Y, Nagai Y, Imai E, Rakugi H, Isaka Y, Hayashi T.
Nephrol Dial Transplant. 2011 Jun;26(6):1838-46.
11 Endothelial dysfunction as a potential contributor in diabetic nephropathy.
Nakagawa T, Tanabe K, Croker BP, Johnson RJ, Grant MB, Kosugi T, Li Q.
Nat Rev Nephrol. 2011 Jan;7(1):36-44.
12 Evaluation of GFR Measurement Method as an Explanation for Differences Among GFR Estimation Equations.
Dai SS, Yasuda Y, Zhang CL, Horio M, Zuo L, Wang HY.
Am J Kidney Dis. 2011 Sep;58(3):496-8.
13 Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities.
Stevens LA, Claybon MA, Schmid CH, Chen J, Horio M, Imai E, Nelson RG, Van Deventer M, Wang HY, Zuo L, Zhang YL, Levey AS.
Kidney Int. 2011 Mar;79(5):555-62.
14 Growth factor Midkine is involved in the pathogenesis of renal injury induced by protein overload containing endotoxin.
Kato K, Kosugi T, Sato W, Arata-Kawai H, Ozaki T, Tsuboi N, Ito I, Tawada H, Yuzawa Y, Matsuo S, Kadomatsu K, Maruyama S.
Clin Exp Nephrol. 2011; 15: 346-354.
15 Increased urethral resistance by periurethral injection of low serum cultured adipose-derived mesenchymal stromal cells in rats.
Watanabe T, Maruyama S, Yamamoto T, Kamo I, Yasuda K, Saka Y, Ozaki T, Yuzawa Y, Matsuo S, Gotoh M.
Int J Urol. 2011; 18: 659-666.
16 Influence of proteinuria on renal Doppler sonographic measurements in chronic kidney disease and in diabetes mellitus.
Nakamori A, Ando Y, Matsuda H, Kimura T, Minami H, Imai E, Yura T.
J Clin Ultrasound. 2011 Nov-Dec;39(9):506-11.
17 Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan.
Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, Tsuruya K, Kiyomoto H, Iida H, Sasaki T, Higuchi M, Hattori M, Oka K, Kagami S, Nagata M, Kawamura T, Honda M, Fukasawa Y, Fukatsu A, Morozumi K, Yoshikawa N, Yuzawa Y, Matsuo S, Kiyohara Y, Joh K, Taguchi T, Makino H.
Clin Exp Nephrol. 2011 Aug;15(4):493-503.
18 Low-serum culture system improves the adipogenic ability of visceral adipose tissue-derived stromal cells.
Nagasaki H, Shang Q, Suzuki T, Hashimoto H, Yoshimura T, Kondo TA, Ozaki T, Maruyama S, Jomori T, Oiso Y, Hamada Y.
Cell Biol Int. 2011 Jun;35(6):559-68.
19 Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study.
Akizawa T, Makino H, Matsuo S, Watanabe T, Imai E, Nitta K, Ohashi Y, Hishida A; Chronic Kidney Disease Japan Cohort Study Group.
Clin Exp Nephrol. 2011 Apr;15(2):248-57.
20 Microarray analysis of tonsils of IgA nephropathy patients.
Iwatani H, Iio K, Nagasawa Y, Yamamoto R, Horii A, Okuzaki D, Inohara H, Nojima H, Imai E, Rakugi H, Isaka Y.
Adv Otorhinolaryngol. 2011;72:75-8.
21 Minimal change disease: a "two-hit" podocyte immune disorder?
Shimada M, Araya C, Rivard C, Ishimoto T, Johnson RJ, Garin EH.
Pediatr Nephrol. 2011 Apr;26(4):645-9.
22 Minimal change disease: a CD80 podocytopathy?
Ishimoto T, Shimada M, Araya CE, Huskey J, Garin EH, Johnson RJ.
Semin Nephrol. 2011 Jul;31(4):320-5.
23 Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin renal clearance.
Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S.
Clin Exp Nephrol. 2011 Dec;15(6):868-76.
24 Peritoneal macrophage infiltration is correlated with baseline peritoneal solute transport rate in peritoneal dialysis patients.
Sawai A, Ito Y, Mizuno M, Suzuki Y, Toda S, Ito I, Hattori R, Matsukawa Y, Gotoh M, Takei Y, Yuzawa Y, Matsuo S.
Nephrol Dial Transplant. 2011; 26: 2322-2332.
25 Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan.
Mizuno M, Ito Y, Tanaka A, Suzuki Y, Hiramatsu H, Watanabe M, Tsuruta Y, Matsuoka T, Ito I, Tamai H, Kasuga H, Shimizu H, Kurata H, Inaguma D, Hiramatsu T, Horie M, Naruse T, Maruyama S, Imai E, Yuzawa Y, Matsuo S.
Clin Exp Nephrol. 2011; 15: 727-737.
26 Regulation of human neutrophil Fcγ receptor IIa by C5a receptor promotes inflammatory arthritis in mice.
Tsuboi N, Ernandez T, Li X, Nishi H, Cullere X, Mekala D, Hazen M, Köhl J, Lee DM, Mayadas TN.
Arthritis Rheum. 2011 Feb;63(2):467-78.
27 Selective Stimulation of VEGFR2 Accelerates Progressive Renal Disease.
Sato W, Tanabe K, Kosugi T, Hudkins K, Lanaspa MA, Zhang L, Campbell-Thompson M, Li Q, Long DA, Alpers CE, Nakagawa T.
Am J Pathol. 2011 Jul;179(1):155-66.
28 Specific collaboration between rat membrane complement regulators Crry and CD59 protects peritoneum from damage by autologous complement activation.
Mizuno T, Mizuno M, Morgan BP, Noda Y, Yamada K, Okada N, Yuzawa Y, Matsuo S, Ito Y.
Nephrol Dial Transplant. 2011; 26: 1821-1830.
29 Splenectomy exacerbates lung injury after ischemic acute kidney injury in mice.
Andrés-Hernando A, Altmann C, Ahuja N, Lanaspa MA, Nemenoff R, He Z, Ishimoto T, Simpson PA, Weiser-Evans MC, Bacalja J, Faubel S.
Am J Physiol Renal Physiol. 2011 Oct;301(4):F907-16.
30 The impact of fructose on renal function and blood pressure.
Kretowicz M, Johnson RJ, Ishimoto T, Nakagawa T, Manitius J.
Int J Nephrol. 2011;2011:315879.
31 Tunneling nanotubes mediate rescue of prematurely senescent endothelial cells by endothelial progenitors: exchange of lysosomal pool.
Yasuda K, Khandare A, Burianovskyy L, Maruyama S, Zhang F, Nasjletti A, Goligorsky MS.
Aging (Albany NY). 2011 Jun;3(6):597-608.
32 Urinary type IV collagen in nondiabetic kidney disease.
Furumatsu Y, Nagasawa Y, Shoji T, Yamamoto R, Iio K, Matsui I, Takabatake Y, Kaimori JY, Iwatani H, Kaneko T, Tsubakihara Y, Imai E, Isaka Y, Rakugi H.
Nephron Clin Pract. 2011;117(2):c160-6.
33 Validation of the equations for estimating daily sodium excretion from spot urine in patients with chronic kidney disease.
Imai E, Yasuda Y, Horio M, Shibata K, Kato S, Mizutani Y, Imai J, Hayashi M, Kamiya H, Oiso Y, Murohara T, Maruyama S, Matsuo S.
Clin Exp Nephrol. 2011; 15: 861-867.